HolderBook

NOVUS THERAPEUTICS INC (NVUS)

Institutional ownership reported to the SEC as of Q4 2020, across 9 quarters.

17
Reporting holders
$87.8M
Reported value
0.0%
Held as options
-1
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
Cormorant Asset Management, LP$21.4M1,415,5000.51%newNEW
FMR LLC$15.5M1,004,1110.00%newNEW
ADAGE CAPITAL PARTNERS GP, L.L.C.$13.7M892,5550.03%newNEW
Woodline Partners LP$13.7M892,5550.36%newNEW
BVF INC/IL$11.8M763,2790.46%newNEW
Logos Global Management LP$3.5M224,0710.30%newNEW
Stonepine Capital Management, LLC$2.6M167,3331.97%newNEW
Maven Securities LTD$1.7M111,5550.17%newNEW
Asymmetry Capital Management, L.P.$1.2M80,0690.56%2q-92.6%-$15.5M
ORBIMED ADVISORS LLC$1.1M73,6500.01%newNEW
MORGAN STANLEY$683.0K44,3780.00%newNEW
RENAISSANCE TECHNOLOGIES LLC$666.0K43,2510.00%newNEW
BlackRock Inc.$165.0K10,6970.00%newNEW
VANGUARD GROUP INC$62.0K4,0430.00%newNEW
Tower Research Capital LLC (TRC)$40.0K2,5980.00%newNEW
Rockefeller Capital Management L.P.$25.0K1,6660.00%newNEW
BANK OF AMERICA CORP /DE/$16.0K1,0200.00%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q4 202017$87.8M5,732,33116010.0%
Q3 202018$6.1M6,464,6779410.0%
Q2 202015$2.8M6,079,1598310.0%
Q1 20209$2.1M5,387,6922130.0%
Q4 20199$2.8M4,870,7631240.0%
Q3 201913$3.4M5,548,0822250.0%
Q2 201920$5.9M5,874,2127920.0%
Q1 201915$13.6M3,377,7723350.0%
Q4 201814$5.4M3,399,7090010.0%